美股詳情

本頁面由Tiger Trade Technology Pte. Ltd.提供服務

三倍做多標普生物-Direxion

250.40

-17.9900-6.70%

盤後：251.981.58+0.63%19:59 EDT

成交量：32.56萬

成交額：8,161.00萬

市值：4.94億

市盈率：- -

高：267.90

開：266.14

低：243.24

收：268.39

52周最高：341.93

52周最低：76.29

股本：197.45萬

流通股本：197.45萬

量比：1.30

換手率：16.49%

股息：1.02

股息率：0.41%

淨資產收益率：--

總資產收益率：--

市淨率：--

市盈率(LYR):- -

資料載入中...

總覽公司新聞資訊公告

醫療健康板塊市場動態綜述

醫療保健板塊動態匯總：市場快訊

美國人口普查局：2025年，92.1%的美國人在部分時段或全年享有醫療保險。

港股異動 | 禮邦醫藥-B(09637)午後飆升逾17% AP308治療IgA腎病新藥臨床申請獲美國FDA批准

鼓勵靈活就業人員參加職工醫保，我國靈活就業人員規模已超過2億人

微博财经-财道工作室

鼓勵靈活就業人員參加職工醫保我國靈活就業人員規模已超過2億人

Biofrontera宣佈Ameluz®紅光光動力療法獲FDA批准用於治療淺表基底細胞癌。

ST萬邦：子公司新生兒HIE新藥WP103獲美國FDA反饋

普洛藥業(000739.SZ)子公司布立西坦片獲得美國FDA批准

醫療保健行業動態：市場快評

普洛藥業：全資子公司布立西坦片獲美國FDA批准

Telix旗下腦癌成像藥物Pixclara獲FDA批准

健康160(02656)開展醫療健康與AI算力融合新業務

推動AI與醫療健康融合發展三項合作亮相服貿會

经济参考网

政策解答！事關泰興職工醫保退休待遇

Scholar Rock宣佈FDA批准ISEMBYLD™，這是首個且唯一針對兒童和成人脊髓性肌萎縮症的肌肉靶向療法。

醫療保健板塊市場綜述：諾華、樂敦、手套製造業與IHH等熱點解析

醫療保健板塊動態：市場快訊綜述

醫療保健板塊動態：市場快訊綜述

美國總統特朗普：我們將直接向美國人發放資金，用於購買醫療保險，並讓他們保留剩餘部分。

{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"Easy breezy. No more feesies.","description":"Tiger Trade is a mobile trading app offering real time data, low commission fees and a free demo account. Download now to start investing in ETFs, options and the global share market.","keywords":"老虎國際,美股交易,港股交易,交易美股,股票信息,股價,美股行情,美股打新,港股打新,IPO打新,購買美股,全球投資","social":{"ogDescription":"Tiger Trade is a mobile trading app offering real time data, low commission fees and a free demo account. Download now to start investing in ETFs, options and the global share market.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.thetigerbrokers.com/hant/stock/LABU/news"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"NZL","license":"TBKIWI","edition":"fundamental","symbol":"LABU","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"LABU\",,,,,undefined,":{"symbol":"LABU","market":"US","secType":"STK","nameCN":"三倍做多標普生物-Direxion","latestPrice":250.4,"timestamp":1789502400000,"preClose":268.39,"halted":0,"volume":325606,"hourTrading":{"tag":"盘后","latestPrice":251.98,"preClose":250.4,"latestTime":"19:59 EDT","volume":8108,"amount":2036460.6035,"timestamp":1789516773600,"change":1.58,"changeRate":0.00631,"amplitude":0.00631},"delay":0,"changeRate":-0.0670293230001117,"floatShares":1974486,"shares":1974486,"eps":0,"marketStatus":"未開盤","change":-17.99,"latestTime":"09-15 16:00:00 EDT","open":266.14,"high":267.9,"low":243.2444,"amount":81609965.98544,"amplitude":0.091865,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":3,"ttmEps":0,"tradingStatus":0,"nextMarketStatus":{"tag":"盤前交易","tradingStatus":1,"beginTime":1789545600000},"marketStatusCode":0,"adr":0,"adrRate":0,"exchange":"ARCA","adjPreClose":268.39,"sharesOutstanding":3074486,"nav":268.659,"aum":530464172.89,"dividendRate":0.00407,"bidAskSpread":0.003539,"preHourTrading":{"tag":"盘前","latestPrice":267.7,"preClose":268.39,"latestTime":"09:25 EDT","volume":476,"amount":126913.024,"timestamp":1789478754552,"change":-0.69,"changeRate":-0.002571,"amplitude":0.027721},"postHourTrading":{"tag":"盘后","latestPrice":251.98,"preClose":250.4,"latestTime":"19:59 EDT","volume":8108,"amount":2036460.6035,"timestamp":1789516773600,"change":1.58,"changeRate":0.00631,"amplitude":0.00631},"volumeRatio":1.297319,"impliedVol":0.9273,"impliedVolPercentile":0.5657},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"LABU\",,,,,undefined,":{"symbol":"LABU","floatShares":1974486,"roa":"--","roe":"--","lyrEps":0,"volumeRatio":1.297319,"shares":1974486,"dividePrice":1.0191,"high":267.9,"amplitude":0.091865,"preClose":268.39,"low":243.2444,"week52Low":76.29,"pbRate":"--","week52High":341.93,"institutionHeld":0,"latestPrice":250.4,"eps":0,"divideRate":0.00407,"volume":325606,"delay":0,"ttmEps":0,"open":266.14,"prevYearClose":159.39,"prevWeekClose":261.3,"prevMonthClose":296.31,"prevQuarterClose":292.1,"fiveDayClose":293.07,"twentyDayClose":287.3,"sixtyDayClose":206.86},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/LABU\",params:#limit:5,,,undefined,":[{"date":"2025-09-23","symbol":"LABU","amount":0.10273,"announcedDate":"2025-09-22","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-09-23","defaultRemindTime":1758634200000,"name":"三倍做多标普生物-Direxion","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-09-30","payableDate":"2025-09-23","currency":"USD","dateTimestamp":1758600000000,"payDate":"2025-09-30"},{"date":"2025-06-24","symbol":"LABU","amount":0.21897,"announcedDate":"2025-06-23","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-06-24","defaultRemindTime":1750771800000,"name":"三倍做多标普生物-Direxion","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-07-01","payableDate":"2025-06-24","currency":"USD","dateTimestamp":1750737600000,"payDate":"2025-07-01"},{"date":"2025-03-25","symbol":"LABU","amount":0.10714,"announcedDate":"2025-03-24","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-03-25","defaultRemindTime":1742909400000,"name":"三倍做多标普生物-Direxion","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-04-01","payableDate":"2025-03-25","currency":"USD","dateTimestamp":1742875200000,"payDate":"2025-04-01"},{"date":"2024-06-25","symbol":"LABU","amount":0.15021,"announcedDate":null,"type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2024-06-25","defaultRemindTime":1719322200000,"name":"三倍做多标普生物-Direxion","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2024-07-02","payableDate":"2024-06-25","currency":"USD","dateTimestamp":1719288000000,"payDate":"2024-07-02"},{"date":"2024-03-19","symbol":"LABU","amount":0.16064,"announcedDate":"2024-03-18","type":"dividend","market":"US","newRecordDate":"2024-03-20","defaultRemindTime":1710855000000,"name":"三倍做多标普生物-Direxion","recordDate":"2024-03-26","payableDate":"2024-03-20","currency":"USD","dateTimestamp":1710820800000,"payDate":"2024-03-26"}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"LABU\",market:\"US\",,,undefined,":[{"executeDate":"2018-06-19","recordDate":"2018-06-20","paymentDate":"2018-06-26","value":0.01932,"currency":"USD"},{"executeDate":"2018-09-25","recordDate":"2018-09-26","paymentDate":"2018-10-02","value":0.0954,"currency":"USD"},{"executeDate":"2018-12-27","recordDate":"2018-12-28","paymentDate":"2019-01-04","value":0.09621,"currency":"USD"},{"executeDate":"2019-03-19","recordDate":"2019-03-20","paymentDate":"2019-03-26","value":0.10973,"currency":"USD"},{"executeDate":"2019-06-25","recordDate":"2019-06-26","paymentDate":"2019-07-02","value":0.03745,"currency":"USD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"LABU\",market:\"US\",delay:false,,,undefined,":{},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"LABU\",pageSize:20,pageCount:1,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"1142651526","title":"醫療健康板塊市場動態綜述","url":"https://stock-news.laohu8.com/highlight/detail?id=1142651526","media":"投资观察","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1142651526?lang=zh_tw&edition=fundamental","pubTime":"2026-09-16 04:52","pubTimestamp":1789505567,"startTime":"0","endTime":"0","summary":"医疗健康领域最新市场快讯，涵盖多家药企与医疗器械公司的股价波动与分析师观点。市场表现方面，阿斯利康股价上涨2.25%，报163.78美元。该股目前下跌1.9%，报113.20瑞郎。杰富瑞对Immutep转持看多立场，分析师David Stanton认为这家生物技术公司的主要候选药物有了更清晰的发展路径。Stanton将评级从持有上调至买入，对该澳大利亚公司关于肺癌研究提前终止似乎与临床因素或试验执行无关的更新感到鼓舞。杰富瑞将目标价翻倍至8澳分。该股持平于4.7澳分。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["XBI","BK4585","LABU","XLV","BK4588","BK4581"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1146582906","title":"醫療保健板塊動態匯總：市場快訊","url":"https://stock-news.laohu8.com/highlight/detail?id=1146582906","media":"投资观察","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1146582906?lang=zh_tw&edition=fundamental","pubTime":"2026-09-16 00:22","pubTimestamp":1789489368,"startTime":"0","endTime":"0","summary":"贝伦贝格的分析师在最新研报中指出，阿斯利康拥有强劲且多元化的产品组合，其研发管线蕴藏着巨大的潜力。他们认为，这家制药巨头当前管线项目有望实现13%的研发投资回报率。尽管2026年一些备受期待的研究结果遭遇挫折，但这些失利已被其他积极成果所抵消，这恰恰凸显了多元化投资组合的重要性。截至发稿，阿斯利康股价上涨2.25%，报163.78美元。该股持平于4.7澳分。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["XLV","BK4581","BK4588","XBI","LABU","BK4585"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667628604","title":"美國人口普查局：2025年，92.1%的美國人在部分時段或全年享有醫療保險。","url":"https://stock-news.laohu8.com/highlight/detail?id=2667628604","media":"格隆汇","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667628604?lang=zh_tw&edition=fundamental","pubTime":"2026-09-15 22:09","pubTimestamp":1789481360,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.gelonghui.com/rss/live/live.xml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_gelonghui","symbols":["XBI","LABU","XLV","BK4588","BK4585","BK4581"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667619385","title":"港股異動 | 禮邦醫藥-B(09637)午後飆升逾17% AP308治療IgA腎病新藥臨床申請獲美國FDA批准","url":"https://stock-news.laohu8.com/highlight/detail?id=2667619385","media":"智通财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667619385?lang=zh_tw&edition=fundamental","pubTime":"2026-09-15 13:36","pubTimestamp":1789450580,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，礼邦医药-B午后飙升逾17%。消息面上，礼邦医药近日宣布，AP308用于治疗IgA肾病的新药临床试验申请近日获美国食品药品监督管理局批准。公司计划于近期启动AP308的首次人体临床试验。AP308的IND获批标志着这一首创新药由临床前研究迈入临床开发阶段。公告指出，IgA肾病是全球最常见的原发性肾小球肾炎，2025年全球患者约950万人，其中中国约510万人，占全球过半。约60%中国患者于确诊后15年内进展至终末期肾病。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1496084.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["09637","BK1574","09939","159938","VXUS","BK1191","BK1515","BK4585","KCAI","LABU","BK1161","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667691484","title":"鼓勵靈活就業人員參加職工醫保，我國靈活就業人員規模已超過2億人","url":"https://stock-news.laohu8.com/highlight/detail?id=2667691484","media":"微博财经-财道工作室","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667691484?lang=zh_tw&edition=fundamental","pubTime":"2026-09-15 07:42","pubTimestamp":1789429320,"startTime":"0","endTime":"0","summary":"来源：@21世纪经济报道微博#灵活就业人员买医保更便利了#“鼓励无雇工的个体工商户、未在用人单位参加职工基本医疗保险的非全日制从业人员以及其他灵活就业人员参加职工基本医疗保险。具体办法由国务院医疗保障行政部门会同国务院有关部门制定。”而根据测算，我国灵活就业人员规模已超过2亿人。于保荣说，医疗保障法“鼓励”灵活就业人员参加职工医保，意味着国家倡导灵活就业人员优先选择参加职工医保。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/wbstock/2026-09-15/doc-inirwfqa8816026.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["XBI","LABU","BK4581","BK4588","BK4585","XLV"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667919386","title":"鼓勵靈活就業人員參加職工醫保我國靈活就業人員規模已超過2億人","url":"https://stock-news.laohu8.com/highlight/detail?id=2667919386","media":"滚动播报","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667919386?lang=zh_tw&edition=fundamental","pubTime":"2026-09-15 07:31","pubTimestamp":1789428660,"startTime":"0","endTime":"0","summary":"“鼓励无雇工的个体工商户、未在用人单位参加职工基本医疗保险的非全日制从业人员以及其他灵活就业人员参加职工基本医疗保险。具体办法由国务院医疗保障行政部门会同国务院有关部门制定。”而根据测算，我国灵活就业人员规模已超过2亿人。于保荣说，医疗保障法“鼓励”灵活就业人员参加职工医保，意味着国家倡导灵活就业人员优先选择参加职工医保。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/jjxw/2026-09-15/doc-inirwfqk3975210.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["LABU","BK4585","BK4588","XBI","XLV","BK4581"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667669789","title":"Biofrontera宣佈Ameluz®紅光光動力療法獲FDA批准用於治療淺表基底細胞癌。","url":"https://stock-news.laohu8.com/highlight/detail?id=2667669789","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667669789?lang=zh_tw&edition=fundamental","pubTime":"2026-09-14 21:26","pubTimestamp":1789392404,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["BK4585","BK4007","LABU","BFRI","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667668376","title":"ST萬邦：子公司新生兒HIE新藥WP103獲美國FDA反饋","url":"https://stock-news.laohu8.com/highlight/detail?id=2667668376","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667668376?lang=zh_tw&edition=fundamental","pubTime":"2026-09-14 19:08","pubTimestamp":1789384138,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["BK4588","LABU","HIE","BK4585"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667165150","title":"普洛藥業(000739.SZ)子公司布立西坦片獲得美國FDA批准","url":"https://stock-news.laohu8.com/highlight/detail?id=2667165150","media":"智通财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667165150?lang=zh_tw&edition=fundamental","pubTime":"2026-09-14 16:55","pubTimestamp":1789376114,"startTime":"0","endTime":"0","summary":"智通财经APP讯，普洛药业(000739.SZ)发布公告，近日，公司全资子公司浙江普洛巨泰药业有限公司(简称“巨泰药业”)收到美国食品药品监督管理局(简称“美国FDA”)的通知，巨泰药业向美国FDA申报的布立西坦片简略新药申请(ANDA，即美国仿制药申请)已获得批准。布立西坦片是一种新型抗癫痫药物，为第二代抗癫痫药左乙拉西坦的衍生物，主要用于治疗部分性发作及相关癫痫类型。据相关数据显示，2025年布立西坦片在美国市场的销售额约为8.23亿美元。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1495643.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["LABU","BK0188","BK4588","BK0239","000739","BK0060","BK4585"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1178480284","title":"醫療保健行業動態：市場快評","url":"https://stock-news.laohu8.com/highlight/detail?id=1178480284","media":"投资观察","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1178480284?lang=zh_tw&edition=fundamental","pubTime":"2026-09-14 16:27","pubTimestamp":1789374430,"startTime":"0","endTime":"0","summary":"基于此，星展将该股年度利息收入预期在2026至2028年间大幅上调76%，同期盈利预估亦调升6%至21%。星展重申对信达生物的买入评级，并维持144.00港元的目标价。该股现报96.75港元，涨幅3.4%。0155 GMT——丰隆投资银行分析师Andrew Lim在报告中表示，马来西亚医疗保健行业在下半年有望延续增长动能，患者数量及人均收入将持续改善。丰隆投银维持对马来西亚医疗保健行业的增持评级，并将IHH医疗保健集团列为板块首选股。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SGXZ24219693.SGD","SG9999004220.SGD","LU1282649810.SGD","IE0003895053.USD","SG9999000475.SGD","LU0488056044.USD","LU0672654166.SGD","LU0588545490.SGD","LU0577902371.SGD","LU0577902454.USD","SG9999002406.SGD","LU0823397285.USD","SG9999009443.AUD","LU0251144936.SGD","SG9999001135.SGD","LU0197773673.USD","SG9999013460.SGD","LU0326948709.USD","LU0197773160.USD","LU0557290698.USD","SG9999005177.SGD","SG9999003826.SGD","LU1839390173.USD","SG9999002604.SGD","IE00BKZH1Z71.USD","LU0165289439.USD","LU1497733557.USD","LU1504937902.USD","LU0823413587.USD","LU2506951875.HKD","SG9999013353.USD","SG9999014492.USD","LU2506951958.HKD","SG9999016042.SGD","LU0029875118.USD","LU2237957811.SGD","SG9999008742.SGD","LU0882747503.HKD","LU0886674414.USD","LU0831093199.SGD","SG9999001127.SGD","LU0823417737.USD","LU1497733631.SGD","LU0320764755.SGD","LU0950375773.USD","LU1634259391.SGD","LU0898667661.SGD","LU1282649141.HKD","LU0441851309.USD","SG9999001226.SGD","LU0251143029.SGD","BK4588","SG9999001903.USD","LU0577902298.EUR","LU1282649067.USD","LU0061477393.USD","SGXZ51708014.SGD","SG9999002414.USD","LU0630378692.HKD","SGXZ43160589.SGD","XBI","LU0971096721.USD","LU0878005551.USD","BK6523","IE0031814969.USD","LU0096374516.USD","SG9999002620.SGD","LU0675040207.SGD","LU1770036033.HKD","LU2152927971.USD","LU0762540952.USD","LU0210637038.USD","LU0315178854.USD","SGXZ23024854.USD","BK6112","LU0011963245.USD","LU0048573645.USD","LU0205439572.USD","SG9999002562.SGD","SG9999014484.SGD","LU1956131251.USD","LU0737861269.HKD","SGXZ70427877.SGD","LU0043850808.USD","SG9999014302.SGD","LU0648948544.HKD","LU0823397103.USD","LU0823413660.USD","LU0211331839.USD","SGXZ44547263.SGD","LU0878004406.USD","LU1497734951.SGD","SG9999000343.SGD","LU0261947096.USD","XLV","LU0955669360.SGD","LU0384037296.USD","LU0543330483.HKD","LU0955623706.USD","LU0856984785.SGD","LU0630378429.USD","LU0345776255.USD","D05.SI","SGXZ91733576.SGD","SG9999001846.SGD","LU0577902538.SGD","LU0441854154.USD","LU0823039010.USD","LABU","LU0048597586.USD","LU0128522157.USD","LU0192582467.USD","LU0819123356.HKD","SGXZ58947870.SGD","LU0831103253.SGD","LU0235996351.USD","BK4585","LU0084288322.USD","SG9999000459.SGD","SG9999004360.SGD","LU2257852520.SGD","LU1522347837.USD","LU0873338254.USD","LU0577902611.USD","SG9999013486.USD","IE00BGHQDM52.EUR","IE00BVYPNQ40.USD","SG9999002679.SGD","LU0188438112.USD","LU0345775950.USD","BK6516","SG9999003800.SGD","SG9999013478.USD","LU1211504680.USD","LU2506952097.USD","LU0261945553.USD","LU3227948356.SGD","LU0955648018.USD","LU1130305938.SGD","LU0865486749.SGD","LU1363072403.SGD","LU2506952170.USD","LU0532188223.SGD","SG9999007991.SGD","LU0169518387.USD","LU0823038988.USD","LU0588545904.SGD","SG9999006266.SGD","LU0819121731.USD","LU1634259557.SGD","SG9999011175.SGD","SGXZ27511609.SGD","LU2237957902.USD","BK4581","SG9999003925.USD","LU0823417653.USD","LU0588545730.USD","LU2238330802.EUR","IE00BVYPNP33.GBP","SGXZ16066938.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667656732","title":"普洛藥業：全資子公司布立西坦片獲美國FDA批准","url":"https://stock-news.laohu8.com/highlight/detail?id=2667656732","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667656732?lang=zh_tw&edition=fundamental","pubTime":"2026-09-14 16:07","pubTimestamp":1789373275,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["BK4585","LABU","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667406636","title":"Telix旗下腦癌成像藥物Pixclara獲FDA批准","url":"https://stock-news.laohu8.com/highlight/detail?id=2667406636","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667406636?lang=zh_tw&edition=fundamental","pubTime":"2026-09-14 08:44","pubTimestamp":1789346648,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["LABU","BK4588","BK4585"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667312635","title":"健康160(02656)開展醫療健康與AI算力融合新業務","url":"https://stock-news.laohu8.com/highlight/detail?id=2667312635","media":"智通财经","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667312635?lang=zh_tw&edition=fundamental","pubTime":"2026-09-14 07:11","pubTimestamp":1789341110,"startTime":"0","endTime":"0","summary":"董事会认为，该解决方案的顺利交付与验收，是本集团在医疗健康与AI算力融合领域新业务路径的重要探索与关键突破节点。本集团注意到，随着AI技术对医疗健康行业应用的不断深入，持续提升，下游客户对“AI应用+算力基础设施”一体化交付的需求正逐步释放。尤其在智能穿戴健康监测、慢病管理等场景中，AI软件平台与算力基础设施的协同部署已成为医疗健康类企业客户实现业务闭环的关键环节。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1495390.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK4588","IXJ","LABU","VHT","BK1197","BK4550","WISE","BK4585","XBI","159760","BK4581","AIO","XLV","WDAI","02656"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667686879","title":"推動AI與醫療健康融合發展 三項合作亮相服貿會","url":"https://stock-news.laohu8.com/highlight/detail?id=2667686879","media":"经济参考网","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667686879?lang=zh_tw&edition=fundamental","pubTime":"2026-09-13 11:50","pubTimestamp":1789271434,"startTime":"0","endTime":"0","summary":"日前，2026年中国国际服务贸易交易会（下称“服贸会”）昌平交易分团举办2026国际健康与环境产业发展系列活动暨中欧跨境产业合作交流会。会上，北京清华长庚医院、北京华医智锦健康科技集团（下称“华医智锦集团”）等开展的“两体融合智联中枢”天健平台启动，AI健康联合研发中心揭牌，AI健康与智联中枢首批协同合作战略协议签署等三项AI健康合作集中亮相。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202609133872792846.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202609133872792846.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["159760","BK4581","BK4588","VTHR","XBI","BK4550","XLV","ARTY","CHAT","IXJ","LABU","VHT","AIPO","AGIX","BK4585","QTOC"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667851836","title":"政策解答！事關泰興職工醫保退休待遇","url":"https://stock-news.laohu8.com/highlight/detail?id=2667851836","media":"泰兴发布","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667851836?lang=zh_tw&edition=fundamental","pubTime":"2026-09-13 10:31","pubTimestamp":1789266660,"startTime":"0","endTime":"0","summary":"我市职工医保退休待遇核定政策解答来了一办理医保退休待遇核定需达到哪些条件？举个例子：2026年泰兴一单位男职工，已交200个月，缴费基数4952元，那么他办理退休时需一次性补缴的医疗保险费用为*10%*4952=49520元；如他有2 年的视同缴费年限，那么他办理退休时需一次性补缴的医疗保险费用为*10%*4952=37635.20元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/wm/2026-09-13/doc-inirrxsc0610142.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["XBI","XLV","BK4581","LABU","BK4585","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666572704","title":"Scholar Rock宣佈FDA批准ISEMBYLD™，這是首個且唯一針對兒童和成人脊髓性肌萎縮症的肌肉靶向療法。","url":"https://stock-news.laohu8.com/highlight/detail?id=2666572704","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666572704?lang=zh_tw&edition=fundamental","pubTime":"2026-09-12 06:25","pubTimestamp":1789165529,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["BK4588","LABU","BK4585"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1147535317","title":"醫療保健板塊市場綜述：諾華、樂敦、手套製造業與IHH等熱點解析","url":"https://stock-news.laohu8.com/highlight/detail?id=1147535317","media":"投资观察","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1147535317?lang=zh_tw&edition=fundamental","pubTime":"2026-09-12 04:56","pubTimestamp":1789160215,"startTime":"0","endTime":"0","summary":"医疗保健板块最新市场快讯速览——本系列报道聚焦于行业动态，为您捕捉关键信息。0110 ET - 野村证券分析报告称，得益于核心品牌在日本及海外市场的强劲销售势头，乐敦制药本财年业绩有望超越其全年指引。花旗预计，这家医疗器械制造商\"中期内可实现可持续的两位数盈利增长，且相比澳新其他医疗股，受消费端波动的影响更小。该股当前下跌1.3%，报43.37新西兰元。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["XBI","XLV","LABU","BK4581","BK4588","BK4585"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1183095065","title":"醫療保健板塊動態：市場快訊綜述","url":"https://stock-news.laohu8.com/highlight/detail?id=1183095065","media":"投资观察","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1183095065?lang=zh_tw&edition=fundamental","pubTime":"2026-09-12 00:22","pubTimestamp":1789143768,"startTime":"0","endTime":"0","summary":"最新一期的医疗保健行业市场快讯已发布，涵盖多家业内重要企业的动态。本综述仅在道琼斯通讯社于美东时间4:20、12:20及16:50独家刊出。美东时间1930 - 花旗对斐雪派克医疗持看多立场，认为该公司为投资者提供了增长性与交付可靠性兼备的投资标的。花旗预计，这家医疗器械制造商“中期内将实现可持续的两位数盈利增长，且相较澳新地区其他医疗类股票，其对消费端波动的敞口更低”。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4585","BK4588","BK4581","LABU","XLV","XBI"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1139785537","title":"醫療保健板塊動態：市場快訊綜述","url":"https://stock-news.laohu8.com/highlight/detail?id=1139785537","media":"投资观察","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1139785537?lang=zh_tw&edition=fundamental","pubTime":"2026-09-11 16:23","pubTimestamp":1789115000,"startTime":"0","endTime":"0","summary":"医疗保健板块最新市场快讯，涵盖多只个股动态与行业趋势。这些信息分别在美东时间4:20、12:20和16:50通过道琼斯通讯社独家发布。2330 GMT——费雪派克医疗保健获得花旗的看涨背书，后者认为该公司既能提供增长潜力，又具备可靠的业绩兑现能力。花旗预计这家医疗器械制造商“中期内将实现可持续的两位数盈利增长，且相较于澳新地区的其他医疗保健类股票，其对消费者动态的敞口较低。”该股现报43.37新西兰元，下跌1.3%。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LABU","XBI","BK4585","XLV","BK4588","BK4581"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666517011","title":"美國總統特朗普：我們將直接向美國人發放資金，用於購買醫療保險，並讓他們保留剩餘部分。","url":"https://stock-news.laohu8.com/highlight/detail?id=2666517011","media":"格隆汇","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666517011?lang=zh_tw&edition=fundamental","pubTime":"2026-09-11 10:28","pubTimestamp":1789093737,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.gelonghui.com/rss/live/live.xml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_gelonghui","symbols":["BK4588","LABU","XBI","BK4581","XLV","BK4585"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":10,"pageCount":1,"totalSize":200,"code":"91000000","status":"200"}]}}